SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001618835-22-000033
Filing Date
2022-02-28
Accepted
2022-02-28 16:01:40
Documents
13
Period of Report
2022-02-22
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K evfm-20220222.htm   iXBRL 8-K 38593
  Complete submission text file 0001618835-22-000033.txt   224090

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evfm-20220222.xsd EX-101.SCH 2292
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evfm-20220222_def.xml EX-101.DEF 16429
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evfm-20220222_lab.xml EX-101.LAB 31730
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evfm-20220222_pre.xml EX-101.PRE 17165
7 EXTRACTED XBRL INSTANCE DOCUMENT evfm-20220222_htm.xml XML 14007
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36754 | Film No.: 22689212
SIC: 2834 Pharmaceutical Preparations